CompoAtlas

Prosvent

Prosvent, licence 80056692: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Therabotanics, LLC
NPN or DIN-HM
80056692
Status
Active licence
Licence date
18 December 2014
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Lycopène tout trans

Source : Solanum lycopersicum - Chair (fruit)

3.0 mgNot calculated
Urtica dioica

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 1800 mg

Potency : 0.8 % beta-Sitosterol

180.0 mgNot calculated
Serenoa repens

Source : Serenoa repens - fruit

Extract : Matériel brut sec

Extraction ratio : 12:1

Dry plant equivalent : 400.8 mg

Potency : 95.0 % Fatty acids

33.4 mgNot calculated

Non-medicinal ingredients

Rouge FD&C N° 40, Gélatine, Corn Oil, Bleu FD&C # 1, Dioxyde de titane, Cire d'abeille, Lécithine, Huile de soja, Glycérine, Eau

PopulationAgeQuantity per servingFrequency
Adultes de sexe masculinNot specified1.0 Capsule3.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to support prostate health. Helps to maintain immune function. Helps in connective tissue formation. Used in Herbal Medicine to help reduce difficulty in urination associated with the early stages of benign prostatic hyperplasia (BPH). The ingredients in Prosvent provide significant relief from the symptoms of an enlarged prostate. Prosvent has beta sitosterol which has been scientifically shown in multiple clinical studies to significantly improve urine flow. Prosvent also contains the antioxidant lycopene to help protect the prostate's health. Saw Palmetto is used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and nighttime urination) associated with mild to moderate benign prostatic hyperplasia.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80056692

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line